Given the rapid proliferation of clinical pathways programs, ASCO has developed, "Criteria for High-Quality Clinical Pathways in Oncology," a set of 15 inter-related criteria that provide an overarching framework to guide stakeholders in the development and implementation pathways—as well as to assess the quality, utility, and integrity of pathways programs in the United States.
In this randomized phase II multicenter trial, patients with metastatic renal cell carcinoma (mRCC) of poor or intermediate risk were randomly assigned to cabozantinib (60 mg once per day) or sunitinib (50 mg once per day; 4 weeks on, 2 weeks off). Compared with sunitinib, cabozantinib treatment significantly increased median PFS (8.2 v 5.6 months) and was associated with a 34% reduction in rate of progression or death.
Practices can now complete all of their Physician Quality Reporting System (PQRS) requirements through QOPI®, ASCO’s Quality Oncology Practice Initiative. QOPI—an oncologist-led, practice-based quality assessment program—is free to all users, and PQRS reporting is free to any practice with an ASCO member.
Searching for an abstract? Looking for a Virtual Meeting video from a session you missed? Find these resources and more at ASCO’s Meeting Library. Access the archives to watch and listen to expert faculty discuss the latest multidisciplinary research, treatment, and care presented during the world-renowned ASCO Annual Meeting. Find exactly what you’re looking for searching by content type.
ASCO Symposia bring together specialists from around the world to offer educational content and the latest scientific discoveries in the respective fields, while providing ample time for networking and collaboration. Upcoming Symposia include the Palliative Care in Oncology Symposium, Gastrointestinal Cancers Symposium, Cancer Survivorship Symposium: Advancing Care in Research, Genitourinary Cancers Symposium and more.
The 2016 Annual Meeting brought together over 30,000 oncology professionals from around the world. Join us next year in Chicago at the 2017 Annual Meeting, featuring world-renowned faculty and educational sessions about state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.